Experts InSight

By: American Academy of Ophthalmology
Listen for free

  • Summary

  • Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology.
    Copyright 2023 American Academy of Ophthalmology
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
Episodes
  • Dilute Hypochlorous Acid for the Treatment of Periorbital Necrotizing Fasciitis

    Dilute Hypochlorous Acid for the Treatment of Periorbital Necrotizing Fasciitis
    Feb 20 2025

    Drs. Louise Mawn and Jonathan Siktberg sit down with host Dr. Amanda Redfern to share their work on a groundbreaking paradigm shift in the treatment of periorbital necrotizing fasciitis with dilute hypochlorous acid.

    For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
    Show more Show less
    25 mins
  • 2025 Retina Update, Part 2: Photobiomodulation, OCT and OCTA Reimbursement, and Surgical Advances

    2025 Retina Update, Part 2: Photobiomodulation, OCT and OCTA Reimbursement, and Surgical Advances
    Feb 7 2025

    Drs. M. Ali Khan and Ajay Kuriyan join host Dr. Jay Sridhar to discuss updates in the retina space, including the FDA approval of photobiomodulation for dry age-related macular degeneration (AMD), OCT and OCTA reimbursement changes, and surgical technology advances.

    For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
    Show more Show less
    28 mins
  • 2025 Retina Update, Part 1: Injectables in the Medical Retina Space

    2025 Retina Update, Part 1: Injectables in the Medical Retina Space
    Jan 23 2025

    Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline.

    For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
    Show more Show less
    44 mins

What listeners say about Experts InSight

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available